Unknown

Dataset Information

Clinical implications of AR alterations in advanced prostate cancer: A multi-institutional collaboration.


ABSTRACT:

Background

AR gene alterations can develop in response to pressure of testosterone suppression and androgen receptor targeting agents (ARTA). Despite this, the relevance of these gene alterations in the context of ARTA treatment and clinical outcomes remains unclear.

Methods

Patients with castration-resistant prostate cancer (CRPC) who had undergone genomic testing and received ARTA treatment were identified in the Prostate Cancer Precision Medicine Multi-Institutional Collaborative Effort (PROMISE) database. Patients were stratified according to the timing of genomic testing relative to the first ARTA treatment (pre-/post-ARTA). Clinical outcomes such as time to progression, PSA response, and overall survival were compared based on alteration types.

Results

In

SUBMITTER: Dorff T 

PROVIDER: S-EPMC10441451 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature